JANSSEN Randomized Study: To Evaluate the Efficacy of Bapineuzumab (ELN115727) in Subjects with Alzheimer’s Disease Who are Apolipoprotein E ε4 Non-Carriers

The PI of this project was:

This project was funded by: Pharma - Elan

The term of this project was: March 2010 to December 2014

The number of subjects scanned during this project was: 8